Antitumor-Promoting Constituents from Dioscorea bulbifera L. in JB6 Mouse Epidermal Cells.
Author:
Affiliation:
1. Department of Traditional Chinese Medicines, Shengyang Pharmaceutical University
2. School of Bioresources, Hiroshima Prefectural University
3. National Institute of Health Sciences
4. School of Pharmaceutical Sciences, University of Shizuoka
Publisher
Pharmaceutical Society of Japan
Subject
Pharmaceutical Science,Pharmacology,General Medicine
Link
http://www.jstage.jst.go.jp/article/bpb/25/9/25_9_1241/_pdf
Reference11 articles.
1. 1) World Cancer Research Fund/American Institute for Cancer Research, “Food, Nutrition and Prevention of Cancer: a Global Perspective,” American Institute for Cancer Research, Washington, 1997.
2. Diosbulbin d and 8-epidiosbulbin e acetate, norclerodane diterpenoids from dioscorea bulbifera tubers
3. 4) Akaha T., Jpn. Kokai Tokkyo Koho JP 08-325159 (1996).
Cited by 105 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A systematic review on ethnobotany, phytochemistry and pharmacology of Dioscorea bulbifera L. (Dioscoreaceae);South African Journal of Botany;2024-07
2. Wound healing activity of hydromethanolic Dioscorea bulbifera extract on male wistar rat excision wound models;Pharmacological Research - Modern Chinese Medicine;2024-06
3. Anti-papillary thyroid carcinoma effects of dioscorea bulbifera L. through ferroptosis and the PI3K/AKT pathway based on network pharmacology and experimental validation;Journal of Ethnopharmacology;2024-05
4. Prediction of network pharmacology, molecular docking-based strategy, and vitro assays to determine potential pharmacological mechanism of Dioscoreae bulbiferae and Bruceae fructus against laryngocarcinoma;Medicine;2023-12-22
5. Diosbulbin C, a novel active ingredient in Dioscorea bulbifera L. extract, inhibits lung cancer cell proliferation by inducing G0/G1 phase cell cycle arrest;BMC Complementary Medicine and Therapies;2023-12-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3